At a glance
ClinicalIndex Comparison RecordN/ACompleted· 229 enrolled
Drug / intervention
20 Gy in 5 fractions +1 moreradiation
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized Phase II/III Study Comparing Stereotactic Body Radiotherapy(SBRT) Versus Conventional Palliative Radiotherapy (CRT) for Patients With Spinal Metastases
In Brief
A clinical study evaluating 20 Gy in 5 fractions and Conventional SBRT: 24 Gy in 2 fractions for Spinal Metastases. Completed, enrolled 229 participants across 22 sites in 2 countries.
Detailed Summary
The purpose of this study is to find out if SBRT is better than CRT at controlling pain in the spine 3 months after receiving treatment.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSpinal Metastases
CountriesAustralia, Canada
CollaboratorsTrans Tasman Radiation Oncology Group
Timeline
N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedJul 2015
Enrollment StartJan 2016
Primary CompletionJul 2020
Study CompletionAug 2021
TodayJul 2026
First PostedJul 31, 2015
Enrollment StartJan 4, 2016
Primary CompletionJul 21, 2020
Study CompletionAug 16, 2021
TodayJul 2, 2026
Enrollment to primary: 4.5 yearsPosted 10.9 years ago
Interventions
20 Gy in 5 fractionsradiation
Conventional SBRT: 24 Gy in 2 fractionsradiation